Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP905563.RA19PBFGQWC7U2NUpYU6vc6JN43DpmOMo2nJruWciOFg0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP905563.RA19PBFGQWC7U2NUpYU6vc6JN43DpmOMo2nJruWciOFg0130_assertion type Assertion NP905563.RA19PBFGQWC7U2NUpYU6vc6JN43DpmOMo2nJruWciOFg0130_head.
- NP905563.RA19PBFGQWC7U2NUpYU6vc6JN43DpmOMo2nJruWciOFg0130_assertion description "[Promoter hypermethylation of PAX6, BRCA2, PAX5, WT1, CDH13 and MSH6 seems to be a frequent early event in breast cancer and methylation levels of GSTP1 (and CDKN2A, although still low) seem to increase with increasing DCIS grade.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP905563.RA19PBFGQWC7U2NUpYU6vc6JN43DpmOMo2nJruWciOFg0130_provenance.
- NP905563.RA19PBFGQWC7U2NUpYU6vc6JN43DpmOMo2nJruWciOFg0130_assertion evidence source_evidence_literature NP905563.RA19PBFGQWC7U2NUpYU6vc6JN43DpmOMo2nJruWciOFg0130_provenance.
- NP905563.RA19PBFGQWC7U2NUpYU6vc6JN43DpmOMo2nJruWciOFg0130_assertion SIO_000772 21710692 NP905563.RA19PBFGQWC7U2NUpYU6vc6JN43DpmOMo2nJruWciOFg0130_provenance.
- NP905563.RA19PBFGQWC7U2NUpYU6vc6JN43DpmOMo2nJruWciOFg0130_assertion wasDerivedFrom befree-2016 NP905563.RA19PBFGQWC7U2NUpYU6vc6JN43DpmOMo2nJruWciOFg0130_provenance.
- NP905563.RA19PBFGQWC7U2NUpYU6vc6JN43DpmOMo2nJruWciOFg0130_assertion wasGeneratedBy ECO_0000203 NP905563.RA19PBFGQWC7U2NUpYU6vc6JN43DpmOMo2nJruWciOFg0130_provenance.